SHINE plans new isotope production facility in the Netherlands

SHINE Medical Technologies plans to locate its European medical isotope production facility in the Netherlands after a yearlong search and a review of more than 50 proposals from sites across Europe. The company announced on May 20 that construction at the site should begin in 2023 with commercial production starting in late 2025.


As a cancer researcher, I am constantly reminded of the horrific impact that breast cancer has on women and their families. This past week I received notification from my boss informing me and others that a work colleague's daughter had recently passed away from breast cancer at the age of 40-certainly this reminder was much closer to home than usual. It is difficult to imagine the pain and suffering my colleague and his wife are now experiencing, adding to what I am sure was a nerve-racking and exhausting period of consultations for the family and treatments for his daughter.